Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Solas Capital Management, LLC | 3.03M | $4.0M | 4.98% | -1.27M | 2026-06-30 |
| Alyeska Investment Group, L.P. | 2.50M | $3.0M | 4.11% | -- | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.41M | $3.0M | 3.97% | +339.2K | 2026-06-30 |
| 683 Capital Management, LLC | 1.07M | $1.0M | 1.75% | -- | 2026-06-30 |
| Centric Wealth Management | 796.7K | $1.0M | 1.31% | -- | 2026-06-30 |
| Cable Car Capital, LP | 514.6K | -- | 0.85% | -133.9K | 2026-06-30 |
| GEODE CAPITAL MANAGEMENT, LLC | 504.4K | -- | 0.83% | +143.9K | 2026-06-30 |
| Bleichroeder LP | 500.0K | -- | 0.82% | -- | 2026-06-30 |
| RENAISSANCE TECHNOLOGIES LLC | 415.7K | -- | 0.68% | -- | 2026-06-30 |
| BlackRock, Inc. | 403.0K | -- | 0.66% | +275.0K | 2026-06-30 |
